Comparison of molecular drug resistance testing and phenotypic drugresistance testing in multi- and extensively drug-resistant tuberculosis

International Health/Infectious Diseases, University of Lübeck, GermanyIntroduction. For the treatment of MDR and XDR tuberculosis, it is important to select the most suitable drug regimen. The resistance testing procedure should be as fast and accurate as possible. Within the framework of personalized medicine, the most suitable therapy approach for the individual patient should be found. With the faster available information from a new form of susceptibility testing, the best regimen could be created in a shorter period of time and the appropriate therapy for the patient could be initiated